Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery. Chu Y, Kordower JH. Mov Disord 2023 Aug 6. doi: 10.1002/mds.29518.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chu Y, Kordower JH. Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery. Mov Disord 2023 Aug 6. doi: 10.1002/mds.29518.
PMID: 37544016